Related Experiment Video
Updated: Apr 27, 2026
10:28
Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
9.1K
Biological prognostic parameters in gastric carcinomas.
Chirurgia (Bucharest, Romania : 1990)
|June 24, 2014
Summary
This study investigated gastric cancer biomarkers, finding p53 and PCNA expression correlated with tumor aggressiveness. Identifying these molecules may improve treatment strategies for gastric cancer patients.
Area of Science:
- Oncology
- Gastroenterology
- Pathology
Background:
- Gastric cancer is a leading cause of cancer mortality globally.
- Gastric carcinogenesis is influenced by diet, habits, and environmental factors.
- Clinicopathological parameters and biomarker expression are crucial for understanding gastric cancer progression.
Purpose of the Study:
- To correlate clinicopathological parameters with p53 and Proliferating Cell Nuclear Antigen (PCNA) expression in gastric cancer patients.
- To investigate the potential of these biomarkers in identifying aggressive tumors.
- To inform therapeutic approaches post-surgical resection.
Main Methods:
- Immunohistochemistry was used to analyze p53 and PCNA expression in 32 gastrectomy specimens.
- Clinicopathological data including staging, differentiation, lymph node status, and survival were collected.
- Epidemiological and clinical characteristics of the patient cohort were assessed.
Main Results:
- The majority of gastric cancers were of the intestinal type (26/32).
- Average p53 protein expression was 20.75%, and PCNA expression was 47.3%.
- Distant metastases were present at surgery in 6 patients and developed in 6 more within 12 months.
Conclusions:
- p53 and PCNA expression levels may serve as indicators of gastric cancer aggressiveness.
- Biomolecular identification can aid in tailoring treatment strategies after surgery.
- Further research is warranted to validate these findings and their clinical utility.
